NCT04913285 2025-12-24A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsPierre Fabre MedicamentPhase 1 Active not recruiting400 enrolled
NCT00673010 2025-10-09Lesion Dosimetry With 124-Iodine in Metastatic Thyroid CarcinomaMemorial Sloan Kettering Cancer CenterPhase 1 Completed20 enrolled